ImmPACT Raises $110m As Bispecific CAR-T Shows Promising Response Rates

Next-Gen Cell Therapy Firm Aims To Solve First-Gen Problems

 
• By Mandy Jackson
  
Blue background with wooden gears. Mind works and new ideas concept.
ImmPACT raised $111m to advance its three big ideas for improving CAR-T therapies • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Financing

More from Business